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ABSTRACT: The storage and transport of cells is a fundamental
technology which underpins cell biology, biomaterials research,
and emerging cell-based therapies. Inspired by antifreeze and ice-
binding proteins in extremophiles, macromolecular (polymer)
cryoprotectants are emerging as exciting biomaterials to enable the
reduction and/or replacement of conventional cryoprotective
agents such as DMSO. Here, we critically study post-thaw cellular
outcomes upon addition of macromolecular cryoprotectants to
provide unambiguous evidence that post-thaw culturing time and a
mixture of assays are essential to claim a positive outcome. In
particular, we observe that only measuring the viability of recovered cells gives false positives, even with non-cryoprotective
polymers. Several systems gave apparently high viability but very low total cell recovery, which could be reported as a success but in
practical applications would not be useful. Post-thaw culture time is also shown to be crucial to enable apoptosis to set in. Using this
approach we demonstrate that polyampholytes (a rapidly emerging class of cryoprotectants) improve post-thaw outcomes across
both measures, compared to poly(ethylene glycol), which can give false positives when only viability and short post-thaw time scales
are considered. This work will help guide the discovery of new macromolecular cryoprotectants and ensure materials which only give
positive results under limited outcomes can be quickly identified and removed.
■ INTRODUCTION
The banking of cells underpins all cell biology and biomaterials
research, removing the need for continuous culture (which
results in phenotype drift,1 as well as consuming large amounts
of resources) and enables successful delivery of emerging cell-
based therapies.2,3 Conventional cryoprotectants (CPAs),
which protect the cells from cold-associated stress during
freezing, include DMSO (the most common), glycerol,
trehalose, and sucrose.4 While DMSO is still the gold standard
cryoprotectant, it is desirable to reduce or remove DMSO due
to toxicity issues,5 epigenetic changes,6 and DMSO sensitivity
with certain cells (e.g., RAW 264.7).7 To address this, there
has been a resurgence of interest in the discovery of molecules
and materials which can modulate the damage during
cryopreservation,8−12 initially inspired by how extremophiles
survive subzero temperatures.13,14 These organisms produce
antifreeze proteins (AFP) and antifreeze glycoproteins
(AFGP),15,16 which demonstrate potent ice recrystallization
inhibition (IRI) activity, a key cause of cell death during
thawing in vitro.17,18 Biomaterials that mimic the IRI
properties of AFPs,19,20 such as poly(vinyl alcohol) (PVA),
have been shown to improve post-thaw cell recoveries.21−23
Other IRI active examples include polyproline,24,25 small
molecules,26 and graphene oxide.27 Polyampholytes (polymers
containing a mix of both positive and negative charges) have
emerged as a new class of macromolecular cryoprotectant,
which (while having some IRI activity)28 appear to work by an
alternative mechanism which might include membrane
stabilization.11,29,30 The first polyampholyte used in cryopre-
servation was reported by Matsumura et al. using a
carboxylated ε-poly-L-lysine derivative for DMSO-free cry-
opreservation.11 Polyampholytes have been used to success-
fully cryopreserve stem cells,31 cell monolayers,32 and mouse
oocytes.33 Structure−property relationships for these materials
are still missing however.34
One particular challenge in this emerging biomaterials field
is that there is no standardized test for assessing a
cryoprotectant for cell recovery, and there are many cell lines
(or primary cells) which survive freezing differently. Therefore,
it is currently hard to compare how potent two macro-
molecular cryoprotectants are. It is clear, however, that there is
a mismatch between the two common methods for measuring
cryoprotective outcome: the viability of the cells recovered
(the ratio of live cells to total cells post-thaw, this is most
commonly reported)35−37 and the total number of cells
recovered (the ratio of total live cells post-thaw to total cells
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initially frozen), with the former tending to give higher values
than the latter. Furthermore, the post-thaw interval differs
between studies, from analyzing cells immediately, to up to 48
h post-thaw. These two factors are especially crucial when
assessing new macromolecular cryoprotectants which may
function by different mechanisms (compared to conventional
CPAs) and result in unanticipated stresses (or protection).9
For example, Stöver and co-workers reported polyampholytes
for DMSO-free cryopreservation;38 cell viabilities immediately
post-thaw were similar to that of 10% DMSO, but the cells did
not adhere well, and post-thaw growth curves suggested the
polymer did not produce viable cells unless additional DMSO
was added. Matsumura used vitrification (using 6.5 M ethylene
glycol) for mesenchymal stromal (stem) cell cryopreservation
with added polyampholytes.39 Near 100% cell viability could
be achieved, but post-thaw growth rates were suppressed
relative to controls (but superior to conventional vitrification).
Crucially, the number of cells at zero hours (post-thaw) was
greater than after 1 day culture. Similarly, Sharp et al. observed
lower cell densities after 24 h compared to immediately post-
thaw.40 Yang and co-workers measured cell survival over time
(after cryopreservation) and found it peaked at 1−2 h post-
thaw but decreased after 24 h incubation,41 highlighting that
immediate post-thaw measurements lead to significant over-
estimation of cryoprotectant activity. Mercado et al. showed
that adding an amphiphilic polymer to SAOS-2 cells along with
200 mM trehalose gave a cryoprotective benefit but found
significant differences between the two assessment methods
(trypan blue and MTS assay) when the cells were analyzed
immediately post-thaw.42 These studies further highlight that
immediate post-thaw values can fail to predict long-term
cryoprotective outcomes; clearly, the primary aim of
cryopreservation must be to obtain sufficient numbers of
viable cells suitable for experiments or therapy, and new
cryoprotective biomaterials should be designed to achieve this.
Considering the above, it is clear that the potential for false
positives in this emerging field of macromolecular cryopro-
tectants is significant and that single measurements (especially
viability) can give the impression of exceptional cryopreserva-
tion performance when in reality few cells are recovered.
Therefore, the aim of this manuscript is to critically evaluate
the post-thaw culture conditions and assessment methods on
the outcome of cellular cryopreservation upon addition of
several polymers. It is shown that short culture times post-thaw
lead to severe overestimation of cryoprotectant function and
that the use of viability measurements alone also gives
significant false positives. We hope this will help guide the
development of new materials for this important biotechno-
logical process.
■ EXPERIMENTAL SECTION
Materials. Advanced Dulbecco’s Modified Eagle’s Medium, Ham’s
F-12K media, and penicillin/streptomycin/amphotericin B were
obtained from Gibco. Poly(ethylene glycol) (Mn 8 kDa) was obtained
from MP Biomedicals. Dimethylaminoethanol, dimethyl sulfoxide,
fetal bovine serum, Dulbecco’s phosphate-buffered saline, poly-
(ethylene glycol)methyl ether (Mn 20 kDa), and poly(methyl vinyl
ether-alt-maleic anhydride) (Mn 80 kDa) were obtained from Sigma-
Aldrich. A live/dead viability/cytotoxicity kit and CellEvent Caspase-
3/7 Green Detection Reagent were obtained from Thermo Fisher. All
solvents were purchased from VWR or Sigma-Aldrich, and reagents
were used without further purification unless indicated.
Methods. Polyampholyte Synthesis. Polyampholyte was synthe-
sized as previously described.32 Briefly, poly(methyl vinyl ether-alt-
maleic anhydride), average Mn 80 kDa (1 g), was dissolved in
tetrahydrofuran (50 mL) and heated to 50 °C with stirring, Scheme 1.
Once dissolved, dimethylaminoethanol (2 g) was added in excess,
forming a pink waxy solid, which was allowed to stir for 30 min. Water
(50 mL) was added, and the reaction was left to stir overnight
followed by purification in dialysis tubing (Spectra Por, 12−14 kDa
MWCO) for 48 h. The resulting solution was freeze dried to produce
a white solid.
Cell Culture. Human caucasian lung carcinoma A549 cells
(ECACC 86012804) and human colon adenocarcinoma SW480
cells (ECACC 87092801) were obtained from the European
Collection of Authenticated Cell Cultures and cultured in Ham’s F-
12K media (Gibco) and Advanced Dulbecco’s Modified Eagle’s
Medium (DMEM) (Gibco), supplemented with 10% fetal bovine
serum (FBS) (Sigma-Aldrich), 100 units·mL−1 penicillin, 100 μg·
mL−1 streptomycin, and 250 ng·mL−1 amphotericin B (PSA). Cells
were maintained in a humidified atmosphere at 37 °C, 5% CO2, and
subcultured every 3−4 days or when 90% confluent.
Cryopreservation of Cell Suspensions. Polymer cryoprotectants
were prepared at a 2× final concentration in culture media containing
20% FBS and 5% DMSO and allowed to dissolve before sterile
filtering through a 0.2 μm membrane. Cells were removed from
culture by treatment with 0.25% trypsin plus 1 mM ethyl-
enediaminetetraacetic acid (EDTA) in balanced salt solution for 5
min at 37 °C before being neutralized with complete cell culture
media and centrifuged at 180 × g for 5 min. Supernatant was
removed, a sample of cells was diluted 1:1 with 0.4% trypan blue, and
the number of viable cells was determined by counting with a
hemocytometer. The cell density was adjusted to obtain a cell
suspension containing 2 × 105 cells·mL−1, and a second cell count was
performed to obtain an accurate prefreeze value. A 500 μL amount of
cell suspension was added to 500 μL of cryoprotectant solution in a
cryovial and mixed 3 times. Final polymer solutions consisted of 10%
FBS, 2.5% DMSO, and 20 mg·mL−1 polymer. Triplicate samples were
prepared for each freezing condition. The cryovials were transferred
to a CoolCell freezing box and frozen at 1 °C·min−1 in a −80 °C
freezer. After 2 h at −80 °C the cryovials were transferred to liquid
nitrogen storage for 24 h. To thaw, cryovials were removed from
liquid nitrogen and suspended in a water bath heated to 37 °C. The
contents of each vial were added to 9 mL of complete media and
centrifuged at 180 × g for 5 min to pellet cells. The supernatant was
discarded, and the cell pellet was resuspended in 500 μL of complete
cell media and then transferred to individual wells of a 24-well plate.
Plates were maintained in a humidified atmosphere at 37 °C, 5% CO2
for either 6 or 24 h.
For samples analyzed immediately post-thaw (0 h time point),
cryovials were thawed as described above. After centrifugation, the
supernatant was removed and cells were resuspended in 400 μL of
complete cell media. A sample of the cell suspension was used for the
trypan blue exclusion assay. For samples analyzed 6 or 24 h post-thaw,
the supernatant in the well was collected and cells were washed once
with 250 μL of PBS. The PBS wash was combined with the well
supernatant, centrifuged at 180 × g for 5 min, and then resuspended
in 100 μL of complete media. The cells were counted using a
hemocytometer to determine the number of nonattached cells post-
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thaw. Following PBS wash, the cells in the well plate were treated with
0.25% trypsin plus 1 mM ethylenediaminetetraacetic acid (EDTA) in
balanced salt solution for 5 min at 37 °C, 5% CO2, neutralized with
complete cell media, and centrifuged at 180 × g for 5 min. The
supernatant was removed, and cells were resuspended in 400 μL of
complete media.
Trypan Blue Exclusion Assay. For all time points, a sample of cells
was mixed 1:1 in 0.4% trypan blue and counted using a
hemocytometer. Cell recovery was calculated as the ratio of unstained
cells to the number of cells initially frozen. Cell viability was calculated
















Live/Dead Viability Assay. Cells were frozen with cryoprotectant
solutions and thawed as described and plated into 24-well plates. After
either 6 or 24 h post-thaw, cell media was removed and cells were
washed with 300 μL of sterile phosphate-buffered saline. A live/dead
solution was prepared in sterile PBS containing 2 μM calcein-AM and
4 μM ethidium homodimer-1 and vortexed to mix. A 250 μL amount
of live/dead solution was added to each well, and the plate was
incubated at room temperature protected from light for 30 min. After
30 min, phase contrast and fluorescence images were captured for two
different areas of each well at 530 and 645 nm on a CKX41
microscope with pE-300-W LED illumination and a XC30 camera.
Four wells were analyzed for each condition. Image analysis was
performed using ImageJ software, version 1.52. Cell viability was
calculated as the ratio of cells stained with calcein-AM (green
fluorescence) to the sum of cells stained with calcein-AM (green











Apoptosis Assay. Cells were frozen with cryoprotectant solutions
and thawed as described above. The number of viable cells for each
sample was determined by the trypan blue exclusion assay using a
hemocytometer, and the cell density was adjusted to 1 × 105 cells·
mL−1. A 100 μL amount of each sample was added to individual wells
of a 96-well plate (1 × 104 cells·well−1). CellEvent Caspase-3/7 Green
Detection Reagent was prepared in complete cell media at 2× final
concentration (8 μM, final concentration 4 μM), and 100 μL was
added to all wells. Plates were maintained in a humidified atmosphere
at 37 °C, 5% CO2 until ready for analysis. At 6 and 24 h post-thaw,
phase contrast and fluorescence images (Ex/Em 502/530 nm) were
captured on a CKX41 microscope with pE-300-W LED illumination
and a XC30 camera. Image analysis was performed using ImageJ
software, version 1.52.
■ RESULTS AND DISCUSSION
Two model cell lines were employed in this work, A549 and
SW480. These were chosen as we found them useful for
screening for cryopreservation outcomes and are easily
available (unlike, e.g., primary cells). They have doubling
rates of 24−48 h,43 allowing the study of proliferation (and
onset of apoptosis) within a reasonable time frame in the
laboratory. With these a panel of polymers was selected based
on their reported cryoprotective, or lack of, properties. A
polyampholyte comprising a poly(methyl vinyl ether-alt-maleic
anhydride) backbone functionalized with dimethylaminoetha-
nol (Figure 1), which has been shown to increase suspension
and monolayer cell cryopreservation, was synthesized accord-
ing to previous procedures.32 This polymer is only weakly IRI
active, with its mechanism of action suggested to be due to
Figure 1. Polymers used in this study.
Figure 2. Post-thaw outcomes of cryopreserved A549 cells. (A−C)
Phase contrast images 24 h post-thaw, after cryopreservation in the
indicated conditions. Recoveries calculated by trypan blue exclusion
assay. (D−F) Fluorescence microscopy images of A549 cells 24 h
post-thaw, cryopreserved in the indicated conditions. Cells stained
with calcein-AM (green fluorescence) and ethidium homodimer-1
(red fluorescence). Cell viability calculated from live/dead assay. Scale
bar 100 μm.
Figure 3. Schematic showing a comparison between reporting the
total cell recovery and the cell viability of frozen and thawed cells
using the live/dead assay. (A) Number of cells initially frozen; (B and
C) hypothetical cryoprotective outcomes post-thaw.
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membrane stabilization.32 Poly(ethylene glycol) (PEG) (8 and
22 kDa) was chosen as it is a negative control in ice growth
assays19,20,44 and cryoprotective assays, but in our initial work
(explored below) it was capable of showing false positive
results.
To highlight the need for considering both viability (eq 1)
and total recovery values (eq 2), control experiments with
variable DMSO levels were conducted. A549 cells were
cryopreserved with either 10% (v/v) or 2.5% (v/v) DMSO
and then thawed and plated. After 24 h incubation, cell
viability (live/dead assay) and total cell recovery (trypan blue
exclusion assay) were assessed, Figure 2. If viability of the
recovered population is considered, 10% DMSO gave 94%
viability and 2.5% DMSO gave 80%, suggesting both are
reasonable cryoprotectants. However, viability measurements
(ratio of live to total cells recovered) do not consider the
number of cells lost during the freezing process, leading to
overestimates of success. From the micrographs in Figure 2 A−
C it is clear that far fewer cells are recovered when frozen in
2.5% DMSO (14%) compared to 10% DMSO (55%). This
effect was also apparent when 20 mg·mL−1 PEG (8 kDa) was
added as a cryoprotectant, which showed comparable viability


























To exemplify this, Figure 3 shows a (simplified) schematic
of how different post-thaw outcomes can be interpreted. If 10
cells were cryopreserved (Figure 3A), we show two scenarios.
One scenario is where 8 intact cells are recovered (Figure 3B),
with 6 live and 2 dead. This could be reported as 60% recovery
or 75% viability; clearly different numbers. In the second
scenario (Figure 3C), only 2 cells are recovered (20%
recovery), but as both of them are viable, this is reported as
100% viability. The latter is clearly a “worse” outcome as fewer
cells survived but based on common reporting methods would
Figure 4. Post-thaw total cell recovery of A549 cells. (A) Schematic for calculating percentage recovery. (B−F) Recovery calculated by trypan blue
exclusion. Each plot shows biological repeats, with 3 technical replicates. Error bars are ± SEM. A549 cells were frozen in (B) 10% DMSO, (C)
2.5% DMSO, (D) 20 mg·mL−1 polyampholyte + 2.5% DMSO, (E) 20 mg·mL−1 poly(ethylene glycol) (20 kDa) + 2.5% DMSO, and (F) 20 mg·
mL−1 poly(ethylene glycol) (8 kDa) + 2.5% DMSO.
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be seen as a positive result. This simplistic model highlights the
challenges of making comparisons in this fast-emerging field
and the need to ensure results are comparable and a “positive”
result is true.
To enable a systematic evaluation of how the post-thaw
culture conditions and assay systems can impact the reported
results and to test if the recently reported polyampholytes do
provide a robust cryopreservation enhancement,32 a detailed
post-thaw analysis was undertaken. For each cell line, the
impact of adding 20 mg·mL−1 of the indicated polymer with
2.5% DMSO during cryopreservation was tested. This
concentration was chosen to be non-optimal to allow benefits
of polymers to be evaluated. This reproduces common
conditions used for the discovery of macromolecular
cryoprotectants.32,34 Both cell recovery and cell viability were
measured using the trypan blue exclusion assay, where cells
with compromised membranes take up the cell-impermeable
dye, while cells with intact membranes remain unstained. This
allowed measurement immediately post-thaw, as the live/dead
assay cannot be used accurately at zero hours post-thaw since
the cells have not yet adhered to their culture surface.
Crucially, cells were analyzed at 0, 6, and 24 h time points to
understand how these parameters changed over the post-thaw
interval. High viability after 6 h, which then decreases at 24 h,
is not useful for any procedure or process involving cells and is
a key mechanism for introduction of false positives in the
discovery of cryoprotectants.
In the following sections, data is presented per biological
repeat (with technical triplicates) rather than averaged to
ensure trends are not smoothed out (averaged data is included
in the Supporting Information, Figures S1−S4). Figure 4
shows the post-thaw total cell recovery for A549 cells under
the indicated conditions. Using 2.5% DMSO as a cryopro-
tectant led to apparent cell recoveries between 16% and 23%,
which decreased after 6 and 24 h in culture. In general,
addition of any polymer showed some overall increase,
especially using immediate post-thaw measurements. Similar
recoveries were observed between 0 and 24 h for the
polyampholyte and 20 kDa PEG (both with 2.5% DMSO),
suggesting the recovered cells were capable of attaching and
proliferating.
However, only the polyampholyte cryopreserved cells
showed increases in cell number over time for each biological
repeat. Importantly, the recovery of cells frozen with 8 kDa
Figure 5. Post-thaw cell viability of A549 cells. (A) Schematic for calculating percentage viability. (B−F) Viability data calculated by trypan blue
exclusion. Each plot shows biological repeats, with 3 technical replicates. Error bars are ± SEM Error bars show ± SEM. A549 cells were frozen in
(B) 10% DMSO, (C) 2.5% DMSO, (D) 20 mg·mL−1 polyampholyte + 2.5% DMSO, (E) 20 mg·mL−1 poly(ethylene glycol) (20 kDa) + 2.5%
DMSO, and (F) 20 mg·mL−1 poly(ethylene glycol) (8 kDa) + 2.5% DMSO.
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PEG generally decreased from 0 to 6 and 24 h, similar to 2.5%
DMSO alone. This highlights that recording cell recovery at 0
h post-thaw overestimates the cryoprotective ability of the
polymers and promotes false positives. If recovery data was
only shown at 0 h this could be interpreted as PEG is a potent
cryoprotectant. Recovery after 24 h clearly shows that the cells
die over time and hence are not well cryopreserved.
Next, the viability of the cells was measured using the trypan
blue exclusion assay (eq 3, fraction of recovered cells which
were viable), Figure 5. In all cases, the viability values were
high and failed to capture subtle differences between the
different polymer cryoprotectants. For each condition, a U-
shaped trend was observed across the three time points, where
viability decreased between 0 and 6 h and then increased again
by 24 h post-thaw.
The viability of non-frozen control cells did not show this
trend and remained above 95% at all time points (Figure S5).
This U-shaped response suggests a delayed-onset cryoinjury,
where cells initially appear healthy but then a large degree of
cell death occurs after 6 h in culture. A comparison of this
versus the recovery data from Figure 4 highlights how the
common methods, when used alone, can give very different
outcomes for the same system.
The same conditions were investigated in another cell line to
validate the results. Figure 6 shows the post-thaw total cell
recovery for SW480 cells. In general, cell recoveries were lower
in the SW480 line compared to the A549s, as cryopreservation
is cell line dependent. Cryopreservation with 2.5% DMSO
alone led to cell recoveries of approximately 20% at 0 h, which
decreased further after 6 and 24 h. Similar to the A549s, adding
polymers provided some improvement to total cell recovery.
Cryopreservation with the polyampholyte + 2.5% DMSO led
to comparable recovery values at 0 and 24 h with a dip after 6
h, suggesting some cell death occurred, followed by
proliferation. As seen with A549s, total cell recovery
immediately post-thaw dramatically overestimated the degree
of cryoprotection compared to 24 h when PEG (8 and 20
kDa) was added as a cryoprotectant.
Cell viabilities were also recorded for SW480 cells using the
trypan blue assay at 0, 6, and 24 h post-thaw. Viabilities of
SW480 cells immediately post-thaw appeared high but
dropped substantially between 0 and 6 h, and in some cases,
the cells did not recover at all after 24 h in culture, Figure 7.
Figure 6. Post-thaw total cell recovery of SW480 cells. (A) Schematic for calculating percentage recovery. (B−F) Recovery calculated by trypan
blue exclusion. Each plot shows biological repeats, with 3 technical replicates. Error bars are ± SEM. SW480 cells were frozen in (B) 10% DMSO,
(C) 2.5% DMSO, (D) 20 mg·mL−1 polyampholyte + 2.5% DMSO, (E) 20 mg·mL−1 poly(ethylene glycol) (20 kDa) + 2.5% DMSO, and (F) 20
mg·mL−1 poly(ethylene glycol) (8 kDa) + 2.5% DMSO.
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For example, at 0 h post-thaw, the viability of SW480 cells
cryopreserved with PEG (8 kDa) + 2.5% DMSO was 90−95%,
but in once instance, this dropped to less than 60% after 6 h
and, in one instance to 16% after 24 h. This provides further
evidence that assessing cryopreservation immediately post-
thaw overlooks delayed cryoinjury and leads to false-positive
outcomes. Similar results have been described by other groups;
Stöver reported DMSO-free cryopreservation of 3T3 cells with
polyampholytes that showed >80% cell viabilities immediately
post-thaw.38 However, after plating the cells and culturing for
1−3 days, they observed slower growth rates and fewer cells
than expected, which could only be rescued by addition of 2%
DMSO into the cryoprotective media. This finding would have
been overlooked if only short-term culture conditions had been
included. Mercado et al. reported the outcome of freezing
osteosarcoma cells using an amphipathic polymer alongside
200 mM trehalose.42 While the number of viable cells
(assessed by trypan blue) was higher in the presence of the
polymer, cryosurvival by MTS assay was much lower. This
could be due to low numbers of total recovered cells
(overlooked by viability), which was highlighted only by
using two different methods to assess cryosurvival.
Delayed onset apoptosis (programmed cell death) is the
most likely cause of the U-shaped post-thaw trend, as the
apoptotic cycle (which can take anywhere between 2 and 48 h
depending on multiple factors)45 has not had time to initiate
and complete immediately post-thaw. Using viability or
counting at this point fails to identify apoptotic or pre-
apoptotic cells.46 Cryopreservation-induced apoptosis47 has
been observed in embryonic stromal (stem) cells,48 hepato-
cytes,49 and sperm.50 It has previously been reported that a loss
of cell viability post-thaw has been attributed to apoptosis.51,46
To evaluate apoptosis after cryopreservation, the activity of
caspase-3 and caspase-7, which are highly activated during
apoptosis,52 was measured at 6 and 24 h post-thaw, in both cell
lines, using the aforementioned cryoprotectants. To avoid bias,
the thawed cells were counted and plated at the same density
(1 × 105 cells·mL−1). From the micrographs (Figures S6−9),
caspase-3 and -7 activity was present in all frozen samples
(green fluorescence) at both 6 and 24 h post-thaw, strongly
suggesting that apoptosis had been initiated. In addition,
positively stained cells also displayed morphological shrinkage,
a further trait of apoptosis.53 Importantly, substantial caspase-3
or -7 activity was not observed in non-frozen control cells,
Figure 7. Post-thaw cell viability of SW480 cells. (A) Schematic for calculating percentage viability. (B−F) Viability data calculated by trypan blue
exclusion. Each plot shows biological repeats, with 3 technical replicates. Error bars are ± SEM. SW480 cells were frozen in (B) 10% DMSO, (C)
2.5% DMSO, (D) 20 mg·mL−1 polyampholyte + 2.5% DMSO, (E) 20 mg·mL−1 poly(ethylene glycol) (20 kDa) + 2.5% DMSO, and (F) 20 mg·
mL−1 poly(ethylene glycol) (8 kDa) + 2.5% DMSO.
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suggesting that treatment with trypsin, centrifugation, and
replating was not the cause of apoptosis in the cryopreserved
samples. This finding is supported by guidelines by Galluzzi et
al., who advocate using multiple, complementary assays to
confirm cellular death, including assessment of long-term
survival to detect delayed cell death, such as apoptosis.54
The data above provides conclusive evidence that short (or
nonexistent) culture times post-thaw and only considering cell
viability overestimates the potency of macromolecular
cryoprotectants and can give the impression that a new
material has cryoprotective function. To summarize this, we
collated the averaged data and created a scatter plot, Figure 8.
The bottom right quadrant (high recovery and no viability) is
not possible to achieve (as recovery does not include non-
viable cells). Most of the conditions tested here fell into the
top left quadrant of high cell viability but low recoveries.
Interestingly, only the polyampholytes enabled rescue of 2.5%
(v/v) DMSO cryopreservation into the top-right quadrant of
both high viability and recovery. Example images of different
conditions using live/dead staining 24 h post-thaw are shown
on the scatter plot. This shows, for example, how addition of 8
kDa PEG to 2.5% DMSO gives a minor increase in recovery
but no benefit to viability, whereas 10% DMSO (current
standard) performs well by both measures. The polyampholyte
supplemented with 2.5% DMSO is the only macromolecular
system which gives benefits in both measures and shows it
matches or even outperforms compared to 10% DMSO
cryopreservation. This highlights the necessity of performing
cell counting and monitoring post-thaw outcomes to remove
false positives from spreading in this emerging field.
■ CONCLUSIONS
Here, we present how measuring cryopreservation outcomes
can generate false positives when only cell viability is
considered. We highlight that measuring cell viability alone
leads to overestimation of the activity of some macromolecular
materials. We demonstrated that using net recovery of viable
cells provides a much more robust measure of cryoprotective
outcome. Further, analysis of both cell viability and recovery
over a 24 h period demonstrated that post-thaw culture time is
essential to allow apoptosis to progress, which is crucial to
account for delayed cryoinjury and confirm that remaining
cells are healthy (which in a biomedical context is essential).
Using PEG as a negative control, we showed that standard
viability measurements can suggest significant increases in
post-thaw outcomes, but when compared to the total number
of cells, it is clear that PEG enhances cryopreservation in only a
few cases. Combining the results in a 2-D analysis, it was
observed that polyampholytes do indeed enhance post-thaw
outcomes across all measures and that PEG can give false
positives with high viability values yet low net cell recoveries.
These results will help guide the discovery of macromolecular
cryoprotectants, remove the large potential for false positives,
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